JAMA. 1979 Mar 9;241(10):1003-7.

Prevention of Russian influenza by amantadine.

Abstract

We tested the effectiveness of amantadine hydrochloride in prevention of illness and infection caused by Russian (h1n1) influenza. The trial lasted seven weeks and was double-blind and placebo controlled. The dosage used was 200 mg daily. Efficacy in prevention of serologically confirmed clinical influenza was 70.7%. Efficacy in prevention of infection, symptomatic or asymptomatic, was 39.4%. Side effects seen were all mild, began within two days of the start of the trial, and terminated rapidly on cessation of prophylaxis. The withdrawal rate attributable to use of amantadine was 6.2%. Those who continued to receive prophylaxis for the remainder of the trial did not exhibit excess side effects. It is concluded that amantadine is safe and effective in prophylaxis of H1N1 strains, as has been shown previously for other subtypes of A influenza.

PMID:: 368354; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Amantadine

LinkOut - more resources

Full Text Sources

Supplemental Content

Icon for Silverchair Information Systems

Save items

Related citations in PubMed

Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients. [J Infect Dis. 1980]
Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients.
Pettersson RF, Hellström PE, Penttinen K, Pyhälä R, Tokola O, Vartio T, Visakorpi R. J Infect Dis. 1980 Sep; 142(3):377-83.
Amantadine prophylaxis during an institutional outbreak of type A (H1N1) influenza. [Arch Intern Med. 1986]
Amantadine prophylaxis during an institutional outbreak of type A (H1N1) influenza.
Atkinson WL, Arden NH, Patriarca PA, Leslie N, Lui KJ, Gohd R. Arch Intern Med. 1986 Sep; 146(9):1751-6.
Review A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection. [Can Respir J. 2003]
Review A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection.
Marra F, Marra CA, Stiver HG. Can Respir J. 2003 Oct; 10(7):381-8.
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. [Antiviral Res. 1989]
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A.
Reuman PD, Bernstein DI, Keefer MC, Young EC, Sherwood JR, Schiff GM. Antiviral Res. 1989 Feb; 11(1):27-40.
Review Rimantadine: a clinical perspective. [Ann Pharmacother. 1995]
Review Rimantadine: a clinical perspective.
Wintermeyer SM, Nahata MC. Ann Pharmacother. 1995 Mar; 29(3):299-310.

See reviews... See all...

Cited by 21 PubMed Central articles

Pandemic influenza planning in the United States from a health disparities perspective. [Emerg Infect Dis. 2008]
Pandemic influenza planning in the United States from a health disparities perspective.
Blumenshine P, Reingold A, Egerter S, Mockenhaupt R, Braveman P, Marks J. Emerg Infect Dis. 2008 May; 14(5):709-15.
Review Role of combination antiviral therapy in pandemic influenza and stockpiling implications. [BMJ. 2007]
Review Role of combination antiviral therapy in pandemic influenza and stockpiling implications.
Tsiodras S, Mooney JD, Hatzakis A. BMJ. 2007 Feb 10; 334(7588):293-4.
Vaccines and antiviral drugs in pandemic preparedness. [Emerg Infect Dis. 2006]
Vaccines and antiviral drugs in pandemic preparedness.
Monto AS. Emerg Infect Dis. 2006 Jan; 12(1):55-60.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Prevention of Russian influenza by amantadine.
Prevention of Russian influenza by amantadine.
JAMA. 1979 Mar 9 ;241(10):1003-7.

PubMed
A fatal thrombotic disorder associated with an acquired inhibitor of protein C.
A fatal thrombotic disorder associated with an acquired inhibitor of protein C.
N Engl J Med. 1987 Dec 24 ;317(26):1638-42.

PubMed
Autosomal dominant familial Mediterranean fever-like syndrome with amyloidosis.
Autosomal dominant familial Mediterranean fever-like syndrome with amyloidosis.
Mayo Clin Proc. 1987 Dec ;62(12):1095-100.

PubMed
"Eating lightly" and the self-presentation of femininity.
"Eating lightly" and the self-presentation of femininity.
J Pers Soc Psychol. 1987 Oct ;53(4):693-702.

PubMed
Comparative efficacy of pirprofen and aspirin in rheumatoid arthritis.
Comparative efficacy of pirprofen and aspirin in rheumatoid arthritis.
J Clin Pharmacol. 1979 Jan ;19(1):56-63.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Prevention of Russian influenza by amantadine.

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 21 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information